• Dividend Brief
  • Posts
  • The Dividend Aristocrat With Nearly a 5% Yield Trading Near Multi-Year Lows

The Dividend Aristocrat With Nearly a 5% Yield Trading Near Multi-Year Lows

A consumer staples aristocrat is trading near multi-year lows, yielding close to 5%, and reporting earnings in the next couple weeks. The restructuring story is gaining traction, the valuation is near historic lows, and setups like this rarely stay cheap for long.

July 16, 2026

Every so often, a defensive dividend stock slips into "too cheap to ignore" territory while everyone is busy chasing AI and momentum names. That's the setup here, and the fundamentals back it up.

Standout Picks Now (Sponsored)

Every market cycle produces a handful of companies that dramatically outperform the rest.

Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.

These picks carry the same indicators that historically precede strong rallies.

Past reports highlighted stocks that surged +175%, +498%, and +673%.

Get the Free 5 Stocks Set to Double Report.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Meet the Household Staples Cash Machine

Kimberly-Clark (NYSE: KMB) is what we’re looking at here: the global maker of Huggies, Kleenex, Cottonelle, Scott, Kotex, and Depend. If you have a bathroom or a baby, you own something they make.

At $106.53 a share with a $35.4 billion market cap, the stock trades well off its 52-week high of $137.46 and closer to the low end of its range at $92.42. This is a 53-year dividend grower on sale. You don't get many chances like this.

The Restructuring Story Gaining Real Traction

Here's what caught my eye. Management is deep into its "Powering Care" restructuring plan, targeting substantial cost savings through 2028 by simplifying the supply chain, closing higher-cost facilities, and streamlining operations into two segments: North America and International Personal Care.

The company's joint venture with Suzano for the international family care and personal care business remains on track for a mid-2026 close, which will sharpen the focus on its highest-margin North American and premium brands.

That combination, aggressive cost takeout plus a leaner portfolio, is exactly the type of self-help story the market tends to reward once the numbers show up in earnings. And earnings are right around the corner.

Elite Picks (Sponsored)

This report focuses on a narrow group of stocks identified through a detailed screening process.

Analysts apply a combination of metrics to narrow down potential opportunities.

Past selections have shown strong momentum, but no outcomes are guaranteed.

The newest edition is now open for access.

Get the report now.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

The Numbers Behind the Setup

Strip out the noise from currency drag and divestiture accounting, and the underlying business is doing its job. Gross margins have been climbing as input costs (pulp, resin, energy) roll over from 2023 peaks

Free cash flow generation supports both the dividend and an active buyback program, and the balance sheet is investment-grade with manageable leverage.

The forward P/E sits in the mid-teens, well below where consumer staples aristocrats have historically traded when the sector is in favor.

And with the 10-year yield backing off to 4.54% from earlier highs, the relative appeal of a 4.7%-plus dividend from a defensive name gets sharper by the week.

Action: Start building a position between $102 and $110 ahead of the Q2 earnings report expected in late July. Any gap down on a soft quarter is an opportunity to add, not a reason to bail.

Six months (Sponsored)

Whitney Tilson has built a reputation for identifying major market turning points before they become widely recognized.

Now, he believes the next six months could mark the beginning of a significant shift for both the economy and investors.

In his latest free presentation, he explains what's driving his outlook, the steps he believes investors should consider, and the opportunity he says could outperform traditional assets in the years ahead.

Watch the Free Presentation

Tailwinds You Can Actually Point To

The macro backdrop is working in KMB's favor for the first time in a while. Pulp prices, one of the largest raw material inputs, have normalized after two brutal years. Freight costs have come down.

And the Fed's rate-cutting posture, with the funds rate now at 3.63% and the market pricing more cuts ahead, is pushing income seekers back toward quality dividend names.

There's also a rotation angle. With the S&P 500 up roughly 10% year-to-date and the Nasdaq up 27%, a lot of managers are rotating profits into defensive high-yielders that haven't participated. KMB fits that bill perfectly. It has lagged the broader market, and that gap is your entry.

What Recent Results Actually Show

Prior quarters have shown organic sales growth in the low-single digits with pricing holding up and volumes stabilizing after the post-COVID demand hangover.

Adjusted operating margin has expanded roughly 200 basis points from the trough thanks to the Powering Care initiatives.

The Q2 report is the next test. Consensus is looking for continued margin expansion and reaffirmed full-year guidance. If management raises the outlook or accelerates the cost savings timeline, the stock re-rates.

If they hold guidance, the yield alone gets you paid to wait. Either way, the downside from here looks limited given where the stock already trades relative to its own history.

Why the Dividend Deserves Your Attention

Here's the part that matters most for your income portfolio. KMB pays a $5.08 annual dividend, translating to a trailing yield of roughly 4.77% at current prices. That's near the high end of the stock's 10-year yield range, which historically has been a strong buy signal.

More importantly, this is a 53-year dividend grower. Half a century of raises through recessions, oil shocks, financial crises, and pandemics.

The payout ratio is elevated but supported by consistent free cash flow, and the pending Suzano joint venture close should strengthen the balance sheet even further once it wraps mid-year.

Action:  If you're building an income portfolio and need a defensive anchor, this is one of the highest-quality yields you can get from a company that has been paying and raising for over five decades. Reinvest the dividend and let compounding do the work.

Where the Bear Case Lives

Nothing is bulletproof, and you should know the risks. North America volumes have been sluggish as consumers trade down to private label and store brands in categories like paper towels and tissues. That pressure isn't going away overnight.

Currency headwinds continue to weigh on the international business, and while the Suzano joint venture will reduce that exposure once closed, it doesn't eliminate it. Input costs could reverse if energy prices spike from the Iran situation, and a stronger dollar would hurt reported results.

The payout ratio is on the higher side, which limits how fast dividend growth can accelerate. And if a recession hits harder than expected, even staples names see margin pressure. Position size accordingly.

Putting It Together

Kimberly-Clark is exactly the kind of stock most portfolios are underweight right now. A dominant consumer staples franchise, 53 years of dividend growth, a yield close to 5%, a self-help restructuring story with real cost savings coming through, and a valuation near the low end of its historical range with an earnings catalyst just weeks away.

This isn't a rocket ship. It's a steady compounder yielding nearly 5% that could re-rate higher as the market rotates back toward quality. If you want reliable income with real capital appreciation potential, this belongs on your buy list right now.

Setup Scorecard

Entry Zone: $102 to $110
Target: $125 to $135 over 12 to 18 months
Stop Loss: Reassess below $95

Catalyst Timeline: Q2 2026 earnings expected late July, Powering Care cost savings ramp through 2028, Suzano joint venture expected to close mid-2026

Confidence Level: High. Defensive quality, a near-term earnings catalyst, and a yield near multi-year highs make this an asymmetric setup.

That’s all for today’s edition of the Dividend Brief.

Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!

—Noah Zelvis
DividendBrief.com